Trial Profile
Phase III Study of Gemcitabine Plus Paclitaxel Versus Paclitaxel in Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2012
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 08 Jun 2012 ClinicalTrials.gov record integrated.
- 05 Nov 2010 New trial record.